| Ytd | -22.79% | |
| 1y | -59.14% |
| Open | 1.03 | Prev Close | 1.04 | Low | 1.02 | High | 1.09 | Mkt Cap | 33.58M |
| Vol | 25.32K | Avg Vol | 65.28K | EPS | -0.55 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.14 | Short Ratio | 0.72 | Inst. Own | 0.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-15 | 50-d Avg | 1.11 | 200-d Avg | 1.46 | 1yr Est | 0.00 |
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Limited (“Baird Medic
Gainers Circle8 Group (NASDAQ:CIRC) stock moved upwards by 14.6% to $0.57 during Monday's after
Company Engaged with Interventional Radiology Community at Leading Global Congress in Copenhagen Com
Revenue increase driven by significant growth in the United States and other strategic markets Reven
Shares of Baird Medical Investment Holdings Limited (NASDAQ: BDMD - Get Free Report) traded down 2.5
Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company
NEW YORK, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“
Agreement combines Baird Medical's clinical, regulatory, and global commercialization expertise
NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“
Gainers Gain Therapeutics (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market
First procedures in two new markets highlight growing global adoption of Baird Medical's minimal
First procedures in two new markets highlight growing global adoption of Baird Medical's minimally i
Enhanced U.S. Presence Centralizes Operations as Company Executes Global Growth Strategy NEW YORK, J
Baird Medical Investment (NASDAQ:BDMD) reported quarterly losses of $(0.98) per share. This is a 271
Full year 2025 revenue of $22.5 million, impacted by policy-driven slowdown in Mainland China Advanc
NEW YORK, March 16, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Bai
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company&#
NEW YORK, March 12, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Bai
NEW YORK, March 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Bair
Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical"), a market leader in m
NEW YORK, March 4, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Bair
NEW YORK, March 2, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Bair
Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company
NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Bair
NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Bair
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company&#
NEW YORK, Feb. 11, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Bair
NEW YORK, Feb. 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird
NEW YORK, Jan. 28, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Bai
NEW YORK, Jan. 26, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Bair
Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company&#
Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwav
Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwav
Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company
Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("BAIRD MEDICAL" or the "Company
Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company